Pharmaceutical care: "Why do not we move forward? What is your solution?"

被引：0

|

作者：

Marti, Merce ^{[1
]}

机构：

[1] Fdn Pharmaceut Care, Madrid, Spain

来源：

PHARMACEUTICAL CARE ESPANA | 2011年 / 13卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：159 / 159

页数：1

相关论文

共 50 条

[11] Sport policy evaluation: what do we know and how might we move forward?
Chen, Shushu
INTERNATIONAL JOURNAL OF SPORT POLICY AND POLITICS, 2018, 10 (04) : 741 - 759
[12] WHAT IS A CF MODIFIER AND WHY DO WE CARE?
Drumm, Mitchell L.
PEDIATRIC PULMONOLOGY, 2019, 54 : S107 - S107
[13] The why at IFAR: why do we do what we do?
Smith, Timothy L.
Sedaghat, Ahmad R.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2022, 12 (11) : 1329 - 1329
[14] Why we do what we do
Spinney, L
NEW SCIENTIST, 2004, 183 (2458) : 32 - 35
[15] Why we do what we do
Guenter, Peggi
Simmons, Debora
Hicks, Rodney W.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2008, 32 (05) : 586 - 587
[16] Why We Do What We Do
不详
IEEE CONTROL SYSTEMS MAGAZINE, 2022, 42 (02): : 10 - 12
[17] Why We Do What We Do
Jannuzzi, Christopher J.
ELECTROCHEMICAL SOCIETY INTERFACE, 2020, 29 (01): : 7 - 7
[18] This is Why We Do What We Do
Kondziolka, Douglas
NEUROSURGERY, 2024, 94 (06) : 1105 - 1106
[19] WHAT WE DO, AND WHY WE DO IT
ALEXANDER, L
STANFORD LAW REVIEW, 1993, 45 (06) : 1885 - 1904
[20] WHY DO WE DO WHAT WE DO
BROWN, RD
JOURNAL OF COLLEGE STUDENT DEVELOPMENT, 1984, 25 (06) : 487 - 488

← 1 2 3 4 5 →